Metric Finance
LearnFAQ
LearnFAQ

Learn / IRWD

NASDAQ: IRWD

Ironwood Pharmaceuticals (IRWD) stock, explained like you're 5

Ironwood Pharmaceuticals trades on the Nasdaq under the ticker IRWD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 631 million dollars.

Ticker
IRWD
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 631 million dollars

Is Ironwood Pharmaceuticals a small, medium or large cap company?

No. Ironwood Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 631 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Ironwood Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves IRWD stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Ironwood Pharmaceuticals stock falls on CEO transition news (Investing.com)
  • Ironwood Pharmaceuticals (IRWD) Stock Price, News & Analysis (Stock Titan)
  • IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock? (Yahoo Finance)
  • Ironwood Pharmaceuticals Names Tammi Gaskins as CEO, Effective J (GuruFocus)
  • Ironwood Pharmaceuticals: The Stock Is A Call On The Second Apraglutide Trial Buy (Seeking Alpha)

Follow IRWD in your daily brief

Each trading day at 5 PM ET we post what happened to Ironwood Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow IRWD

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Ironwood Pharmaceuticals stock

What does Ironwood Pharmaceuticals do?

Ironwood Pharmaceuticals trades on the Nasdaq under the ticker IRWD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 631 million dollars.

What is the ticker symbol for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals trades under the ticker IRWD on the Nasdaq.

What is Ironwood Pharmaceuticals's market cap?

Ironwood Pharmaceuticals is a small cap stock with a market cap of about 631 million dollars.

How does Ironwood Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves IRWD stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow IRWD stock every day?

Add IRWD to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow IRWD daily

A free brief on Ironwood Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare IRWD: IRWD vs NVS, IRWD vs AZN, IRWD vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed